20689242|t|Effect of huprine X on beta-amyloid, synaptophysin and alpha7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
20689242|a|BACKGROUND: Several studies implicate acetylcholinesterase (AChE) in the pathogenesis of Alzheimer's disease (AD), raising the question of whether inhibitors of AChE also might act in a disease-modifying manner. Huprine X (HX), a reversible AChE inhibitor hybrid of tacrine and huperzine A, has shown to affect the amyloidogenic process in vitro. In this study, the aim was to investigate whether HX could affect the AD-related neuropathology in vivo in two mouse models. METHODS: Tg2576 (K670M/N671L) (APPswe) and 3xTg-AD (K670M/N671L, PS1M146V, tauP301L) mice were treated with HX (0.12 mumol/kg, i.p., 21 days) or saline at 6-7 months. Human beta-amyloid (Abeta) was measured by ELISA, synaptophysin by Western blot and alpha7 neuronal nicotinic acetylcholine receptors (nAChRs) were analyzed by [(125)I]alpha-bungarotoxin autoradiography. RESULTS: Treatment with HX reduced insoluble Abeta1-40 (about 40%) in the hippocampus of 3xTg-AD mice, while showing no effect in APPswe mice. Additionally, HX markedly increased cortical synaptophysin levels (about 140%) and decreased (about 30%) the levels of alpha7 nAChRs in the caudate nucleus of 3xTg-AD mice, while increasing (about 10%) hippocampal alpha7 nAChRs in APPswe mice. CONCLUSION: The two mouse models react differently to HX treatment, possibly due to their differences in brain neuropathology. The modulation of Abeta and synaptophysin by HX in 3xTg-AD mice might be due to its suggested interaction with the peripheral anionic site on AChE, and/or via cholinergic mechanisms involving activation of cholinergic receptors. Our results provide further evidence that drugs targeting AChE affect some of the fundamental processes that contribute to neurodegeneration, but whether HX might act in a disease-modifying manner in AD patients remains to be proven.
20689242	10	19	huprine X	Chemical	MESH:C404518
20689242	37	50	synaptophysin	Gene	20977
20689242	121	125	3xTg	Disease	
20689242	126	128	AD	Disease	MESH:D000544
20689242	151	155	mice	Species	10090
20689242	195	215	acetylcholinesterase	Gene	11423
20689242	217	221	AChE	Gene	11423
20689242	246	265	Alzheimer's disease	Disease	MESH:D000544
20689242	267	269	AD	Disease	MESH:D000544
20689242	318	322	AChE	Gene	11423
20689242	369	378	Huprine X	Chemical	MESH:C404518
20689242	380	382	HX	Chemical	MESH:C404518
20689242	398	402	AChE	Gene	11423
20689242	423	430	tacrine	Chemical	MESH:D013619
20689242	435	446	huperzine A	Chemical	MESH:C050426
20689242	472	485	amyloidogenic	Disease	
20689242	554	556	HX	Chemical	MESH:C404518
20689242	574	576	AD	Disease	MESH:D000544
20689242	615	620	mouse	Species	10090
20689242	638	644	Tg2576	CellLine	CVCL:S723
20689242	646	651	K670M	ProteinMutation	tmVar:p|SUB|K|670|M;HGVS:p.K670M;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	652	657	N671L	ProteinMutation	tmVar:p|SUB|N|671|L;HGVS:p.N671L;VariantGroup:3;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	672	676	3xTg	Disease	
20689242	677	679	AD	Disease	MESH:D000544
20689242	681	686	K670M	ProteinMutation	tmVar:p|SUB|K|670|M;HGVS:p.K670M;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	687	692	N671L	ProteinMutation	tmVar:p|SUB|N|671|L;HGVS:p.N671L;VariantGroup:3;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	697	702	M146V	ProteinMutation	tmVar:p|SUB|M|146|V;HGVS:p.M146V;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	707	712	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
20689242	714	718	mice	Species	10090
20689242	737	739	HX	Chemical	MESH:C404518
20689242	796	801	Human	Species	9606
20689242	816	821	Abeta	Gene	351
20689242	846	859	synaptophysin	Gene	20977
20689242	957	982	(125)I]alpha-bungarotoxin	Chemical	-
20689242	1024	1026	HX	Chemical	MESH:C404518
20689242	1089	1093	3xTg	Disease	
20689242	1094	1096	AD	Disease	MESH:D000544
20689242	1097	1101	mice	Species	10090
20689242	1137	1141	mice	Species	10090
20689242	1157	1159	HX	Chemical	MESH:C404518
20689242	1188	1201	synaptophysin	Gene	20977
20689242	1302	1306	3xTg	Disease	
20689242	1307	1309	AD	Disease	MESH:D000544
20689242	1310	1314	mice	Species	10090
20689242	1374	1380	APPswe	CellLine	CVCL:D650
20689242	1381	1385	mice	Species	10090
20689242	1407	1412	mouse	Species	10090
20689242	1441	1443	HX	Chemical	MESH:C404518
20689242	1532	1537	Abeta	Gene	11820
20689242	1542	1555	synaptophysin	Gene	20977
20689242	1559	1561	HX	Chemical	MESH:C404518
20689242	1565	1569	3xTg	Disease	
20689242	1570	1572	AD	Disease	MESH:D000544
20689242	1573	1577	mice	Species	10090
20689242	1656	1660	AChE	Gene	11423
20689242	1801	1805	AChE	Gene	11423
20689242	1866	1883	neurodegeneration	Disease	MESH:D019636
20689242	1897	1899	HX	Chemical	MESH:C404518
20689242	1943	1945	AD	Disease	MESH:D000544
20689242	1946	1954	patients	Species	9606
20689242	Association	11423	11820
20689242	Negative_Correlation	MESH:C050426	11423
20689242	Association	MESH:D000544	11820
20689242	Association	MESH:D000544	HGVS:p.K670M;CorrespondingGene:351
20689242	Association	MESH:C404518	11820
20689242	Positive_Correlation	MESH:C404518	20977
20689242	Association	11423	20977
20689242	Association	MESH:D000544	HGVS:p.M146V;CorrespondingGene:351
20689242	Negative_Correlation	MESH:C404518	11423
20689242	Association	MESH:D019636	11423
20689242	Association	MESH:D000544	HGVS:p.P301L;CorrespondingGene:351
20689242	Negative_Correlation	MESH:D013619	11423
20689242	Association	MESH:C050426	MESH:D013619
20689242	Association	MESH:D000544	11423
20689242	Association	MESH:D000544	351

